Not Shocking

Everyone should have seen this coming, so it should surprise no one that Tandem shares fell nearly 16% yesterday or that Insulet and Dexcom feel. As we have noting these three stocks have been hotter than, and damn it’s getting difficult to find new adjectives to describe how hot they have been. The question becomes is the party over or are investors just taking a breather?

Of the three stocks we see Dexcom having the most reasonable chance for moving back upward. The company is just beginning to feel the impact of the G6, has an impressive pipeline and . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.